Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Rufloxacin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2B known ✓ | P18089 | 1/20 | 0.98 |
| ▸ | HRH3 known ✓ | Q9Y5N1 | 1/20 | 0.54 |
| ▸ | TOP1 known ✓ | P11387 | 2/20 | 0.49 |
| ▸ | TOP2A known ✓ | P11388 | 1/20 | 0.49 |
| ▸ | DRD3 known ✓ | P35462 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 9/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 1.00 |
| ▸ | HPGD | P15428 | 6/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.98 |
| ▸ | ALB | P02768 | 1/20 | 0.54 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | TUBB | P07437 | 1/20 | 0.53 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.53 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.53 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.53 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.53 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.53 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Rufloxacin SCHEMBL8390373 | 1.00 | KDM4E (1.00) | KDM4EALDH1A1HPGDHSD17B10ADRA2B | |
| Rufloxacin SCHEMBL8385662 | 1.00 | KDM4E (1.00) | KDM4EALDH1A1HPGDHSD17B10ADRA2B | |
| Rufloxacin SCHEMBL8126704 | 1.00 | KDM4E (1.00) | KDM4EALDH1A1HPGDHSD17B10ADRA2B | |
| Rufloxacin SCHEMBL12505914 | 0.99 | KDM4E (0.98) | KDM4EALDH1A1HPGDHSD17B10ADRA2B | |
| Rufloxacin SCHEMBL838925 | 0.99 | KDM4E (0.98) | KDM4EALDH1A1HPGDHSD17B10ADRA2B | |
| Rufloxacin SCHEMBL574492 | 0.99 | KDM4E (0.98) | KDM4EALDH1A1HPGDHSD17B10ADRA2B | |
| Rufloxacin SCHEMBL135502 | 0.99 | KDM4E (1.00) | KDM4EALDH1A1HPGDHSD17B10ADRA2B | |
| Rufloxacin SCHEMBL23581496 | 0.98 | KDM4E (0.96) | KDM4EALDH1A1HPGDHSD17B10ADRA2B | |
| Rufloxacin SCHEMBL23282883 | 0.98 | KDM4E (0.98) | KDM4EALDH1A1HPGDHSD17B10ADRA2B | |
| Rufloxacin SCHEMBL1651162 | 0.97 | KDM4E (0.96) | KDM4EALDH1A1HPGDHSD17B10ADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 13661 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4551735-A2 | A SYSTEM AND A METHOD FOR ESTIMATING CURRENT EFFICIENCY OF AN ELECTROLYSER | Neovolt OY (FI) | 2025-05-14 | — | — | EP | claimed |
| CN-119506455-A | KASP molecular marking method related to peanut aspergillus flavus seed kernel infection resistance and application thereof | 广东省农业科学院作物研究所 | 2025-02-25 | — | — | CN | claimed |
| CN-113013256-B | Split gate MONOS flash memory and manufacturing method thereof | 上海华力集成电路制造有限公司 | 2024-06-14 | — | — | CN | claimed |
| EP-4381053-A1 | ADENO-ASSOCIATED VIRUS SEPARATION ON A CATION EXCHANGER | Takeda Pharmaceutical Company Limited (JP) | 2024-06-12 | — | — | EP | claimed |
| CN-117980471-A | Adeno-associated virus isolation on cation exchangers | 武田药品工业株式会社 | 2024-05-03 | — | — | CN | claimed |
| WO-2024074623-A1 | DIAGNOSIS, PROGNOSIS AND THERAPY OF NEUROINFLAMMATORY AUTOIMMUNE DISEASES USING CELLULAR AND SOLUBLE BLOOD PARAMETERS | Westfälische Wilhelms-Universität Münster (DE) | 2024-04-11 | — | — | WO | claimed |
| CN-107613213-B | Intelligent camera of embedded platform and image data transmission method thereof | 上海觉感视觉科技有限公司 | 2024-02-20 | — | — | CN | claimed |
| CN-110461869-B | Design of therapeutic immunoglobulin G4 for improved bioassay and bioprocessing characteristics | 百时美施贵宝公司 | 2024-02-06 | — | — | CN | claimed |
| WO-2024009004-A2 | A SYSTEM AND A METHOD FOR ESTIMATING CURRENT EFFICIENCY OF AN ELECTROLYSER | NEOVOLT OY (FI) | 2024-01-11 | — | — | WO | claimed |
| CN-117369615-A | Electronic equipment control method and device, storage medium and electronic equipment | 北京小米移动软件有限公司 | 2024-01-09 | — | — | CN | claimed |
| EP-0248172-B1 | STEREOPHONIC LOUDSPEAKER | SES SOUND ELECTRONIC SYSTEMS S.A. (CH) | 1993-06-02 | — | — | EP | claimed |
| EP-0522277-A1 | Process for the preparation of 9-fluoro-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic acid hydrochloride | MEDIOLANUM FARMACEUTICI s.r.l. (IT) | 1993-01-13 | — | — | EP | claimed |
| CN-1062525-A | Octadecyloxy phenyl aminocompound and manufacture method thereof and the medicament that contains these compounds | KALI CHEMIE PHARMA GMBH (DE) | 1992-07-08 | — | — | CN | claimed |
| CN-1062526-A | Alkylaminoalkylamine and ether compounds, process for producing the same, intermediates for producing the same, and pharmaceutical preparations containing the same | KALI CHEMIE PHARMA GMBH (DE) | 1992-07-08 | — | — | CN | claimed |
| EP-0482130-A1 | PRODUCTION OF MYCORRHIZAL INOCULUM BY STATIC CULTURE HYDROPONICS | MORRISON, Sean (CA) | 1992-04-29 | — | — | EP | claimed |
| US-4868632-A | Nonvolatile semiconductor memory | DIRECTOR GENERAL OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1989-09-19 | — | — | US | claimed |
| EP-0273069-A1 | Glucomannan/polyhydric alcohol composition and film prepared therefrom | UNI COLLOID KABUSHIKI KAISHA (JP) | 1988-07-06 | — | — | EP | claimed |
| EP-0259158-A2 | Semiconductor non-volatile random access memory | AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY MINISTRY OF INTERNATIONAL TRADE & INDUSTRY (JP) | 1988-03-09 | — | — | EP | claimed |
| EP-0248172-A2 | Stereophonic loudspeaker | SES SOUND ELECTRONIC SYSTEMS S.A. (CH) | 1987-12-09 | — | — | EP | claimed |
| EP-0222279-A2 | Production of active proteins containing cystine residues | Cangene Corporation (CA) | 1987-05-20 | — | — | EP | claimed |